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‘Staying Alive in Scotland; Strategies to Prevent Drug Deaths’ was jointly 
published by Scottish Drugs Forum and the Scottish Government in 2016. Any 
loss of life is a tragedy and takes its toll on Scotland’s communities and all of 
us as a nation. In the three years since its publication, we have seen positive 
change in a number of areas, however, despite our successes, rising drug 
related deaths continue to be an area of national concern and is one of the 
most complex challenges to face Scotland.  
A key focus of the new Scottish Government alcohol and drug strategy,  Rights, 
Respect and Recovery, is the need for all of us, whether at a local or national 
or third sector organisation level, to work jointly to deliver change. The vision 
from that strategy states that everyone has the right to health, to live free 
from the harms of alcohol and drugs, to be treated with respect and dignity 
and for their individual recovery journey to be fully supported. I, along with 
my Ministerial colleagues, remain committed to doing all we can to deliver this 
vision, recognising that for many people, substance use sits alongside a variety 
of other issues such as mental health, poverty and inequality, and there is a 
need for all of us to work together to address these.    
The Scottish Drugs Forum has provided us with an easy to use toolkit which 
can be utilised to support local and national delivery plans and deliver a better 
response to those harmed by substance use. The updated toolkit offers sound 
evidence-based steps to prevent drug related deaths.  At a local level, it will 
assist Alcohol and Drug Partnerships and drug services to incorporate good 
practice in to their drug death prevention plans. 
I am pleased that the Scottish Government are able to continue to support the 
Scottish Drugs Forum and ‘Staying Alive In Scotland’, an initiative which will 
continue to save lives. 
Joe FitzPatrick MSP
Minister for Public 
Health, Sport and 
Wellbeing
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There is widespread concern among stakeholders and within the wider public 
discourse, about the extent of drug-related mortality in Scotland. Statistics for 
overdose deaths are released annually by the National Records of Scotland. 
For each of the years 2014 – 2018 these have set new record highs. 
These figures do not include non-overdose deaths related to substance use. 
The overall extent of drug harms in terms of the health and early death are 
hinted at in the Burden of Disease study which shows that drug use is one of 
the most significant causes of years lived with disability and early mortality. 
Analysis of the causes of the stalling of progress in terms of life expectancy in 
Scotland heavily implicates drug use. 
Bacterial infections, cardiovascular disease, respiratory conditions, liver 
disease, cancer and other health conditions, including mental health conditions 
and suicide, all have significant impacts on the lives and deaths of people with 
a drug problem. Wider considerations including the consequences of social 
policy such as welfare reform are also of concern. 
All of this is partly rooted in and complicated by the stigma that is attached to 
drug use and particularly people with a drug problem and now represents a 
significant issue that hinders progress. 
The Scottish Government’s new strategy - Rights, Respect and Recovery: 
Scotland’s strategy to improve health by preventing and reducing alcohol 
and drug use, harm and related deaths - was published in November 2018. 
It contains an ‘Eight-point Plan for Treatment and Recovery’ focussing on 
access to and the quality of treatment and acknowledging the evidence base 
for treatment interventions.   The strategy’s plan also acknowledges that ‘a 
comprehensive approach to harm reduction needs to be embedded within 
recovery-oriented systems of care’. 
This document, approved by Scottish Government and which Scottish Drugs 
Forum developed in consultation with Alcohol and Drug Partnerships and 
other stakeholders lays out the evidence based measures that will reduce 
drug-related deaths; supports commissioners, planners and managers in 
stakeholder organisations to self-audit current provision and practice and to 
work jointly to improve these.  
I welcome the Government’s endorsement of the approaches described here 
and of this publication which was influential in the development of the new 
strategy.  I also welcome the Government’s continued support to Scottish 
Drugs Forum that allows us to work with you to support delivery of this vital 
work.  
I look forward to working with you and other stakeholders in delivering the 
strategy’s aims through the work described here.  We all have a responsibility 
for the current problems and for addressing them – the lives of some of the 
most vulnerable people are at stake.
David Liddell




The original project that produced Staying Alive in Scotland was funded from SDF resources and by 
Scottish Government funding. An internal SDF reference group, including a range of staff oversaw 
and supported the work that resulted in the development of this report. The work was taken forward 
by the National Development Officer (Harm Reduction and Death Prevention). 
This project initially involved direct engagement with all ADPs in Scotland, and a questionnaire was 
sent to 14 pilot areas that explored current work practices, potential gaps and how approaches can 
be further developed to reduce drug-related deaths in Scotland. This initial analysis was used to 
shape a seminar for ADPs to explore the issues further. 
An interim report was then presented to the internal reference group. This report identified key 
work areas and a list of potential Good Practice Indicators which were then were compiled into the 
consultation draft report. 
The consultation report was distributed to all ADPs and other interested parties for comment. The 
consultation report was also discussed with ADPs at a workshop during the workforce development 
reference group. The feedback and subsequent follow up meetings were then used to refine the 
document and include a measurement tool for ADPs to use to assess their current work in this area 
which would help to identify a list of strategic and operational priorities for the coming years. 
Subsequently the document has been edited to make it easier to use and in the light both of emerging 
evidence and practice and Scotland’s new drug strategy, Rights Respect and Recovery.
SDF would like to thank the ADPs who contributed to this work for their open and direct 
communication, the Scottish Government for their support and look forward to working with these 
and other stakeholders to take forward this crucial work.
The number of drug-related deaths has risen sharply and Scotland now has the highest rate of reported 
drug deaths in Europe. There are increased numbers in the over 35 age groups. This could, in part, be 
because of the poor physical health of people who use drugs. There is a need to incorporate findings 
from “Older People with Drug Problems in Scotland: A Mixed Methods Study Exploring Health and 
Social Support Needs” and “Older People with Drug Problems in Scotland: Addressing the Needs 
of an Ageing Population” in order to address the unmet needs of a population at high risk of drug- 
related deaths.
Reducing harms reduces the risk of death and providing services which engage and retain individuals 
is key. Assertive outreach is essential to make contact with those most marginalised and at highest 
risk. Embedding this within our services has been and is continuing to be a challenge. Providing 
evidence based healthcare interventions such as low threshold and optimal prescribing, basic medical 
interventions and working in partnership with the individual are essential. 
In this document there is a focus on identifying underlying physical and mental health conditions and 
supporting people to access treatment with low threshold prescribing and quick access to optimal 
prescribing. There is an emphasis on providing a range of options to allow individuals to work in 
partnership with the services that are supporting them. Referral pathways and information sharing, 
Why Update Now?
Background to Staying Alive in Scotland
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Much of the stigma and discrimination faced by people experiencing problems with drugs links 
directly to an increase in the likelihood of drug-related deaths.
The inter-personal communication and relationships developed between staff and the person using 
the service support positive outcomes. Empathetic, non-judgemental engagement and the quality of 
interaction between staff and the person using the service are crucial.  Consistency of access to the 
same staff encourages people to engage and should be prioritised in terms of management of the 
service.  These factors are valued by people who use services. 
A greater understanding of the needs of people who use drugs can inform training and workforce 
development throughout substance use and related sectors. People who use drugs have, in a variety of 
studies, rated positive attitudes towards them as a key outcome indicator for successful engagement. 
There is a broader need to address the wider stigma in society in relation to people who experience 
problems related to drugs. 
which allow individuals who need further investigations or support to specialists, are an important 
part of increasing the physical resilience of people who use drugs. 
Attitudes and Stigma
The toolkit is split into fourteen chapters each covering a different area of service. Underpinning 
these is an awareness of, and commitment to, reducing the stigma experienced by people who use 
drugs. These chapters are designed utilised independently of each other in order to support the 
particular aims of the service at that time. When used together, they formulate the basis of a drug 
death prevention plan. Workforce considerations are integrated within each chapter as a suggestion 
of how the good practice indicators may be achieved.
It is envisaged that this toolkit would be introduced to staff through development days in which a 
service may choose to pull out a section or sections relevant to that service. Through workshops and 
the involvement of all staff, the Good Practice Indicators in this area would be discussed and a plan 
made of how to achieve these within the service.
The electronic version of the toolkit utilises a traffic light system which allows staff to see at a glance 
where they have achieved the Good Practice Indicators in any given chapter and the likely timescale, 
if not yet achieved. There is also the facility to designate “the responsible individual” and attach any 
supporting policies and procedures, allowing the toolkit to become a larger “one stop” resource 
which would hold all the tools relating to drug-related deaths in one, easily accessible place. Each 
Good Practice Indicator is SMART (Specific, Measured, Achievable, Realistic and Timely).
It is envisaged that, with the roll out of the refreshed and updated document, staff in substance use 
services, and those who work regularly with people who use drugs, will be able to support these 
individuals utilising evidence based practice in order to improve access and help reduce stigma and 
drug-related deaths.
Full references are available in the 2016 original report. 
How to Use this Toolkit
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The Scottish Government’s ‘Rights, Respect and Recovery’ strategy highlights the need to build on 
existing expertise and to ensure that people have the right values, knowledge and experience, as 
well as access to training and ongoing support, to effectively help and support people experiencing 
problems with their drug use.
The emerging workforce development framework describes a conceptual shift away from thinking 
about workforce development primarily at the individual level towards thinking about it in a systemic 
way. 
This broader approach ensures that workforce development activity can effectively respond to 
organisational, individual, systemic and structural factors that negatively impact on organisational 
ability to effectively and efficiently deliver services.  
The specific areas which a workforce development strategy needs to encompass are:
• Initiatives and strategies which address knowledge, attitudes and skills. 
• Supporting strategies for skills and knowledge dissemination – information systems, mentoring 
and research. 
• Workforce structures and policy development/implementation – incentives, performance 
monitoring, job specification, resource allocation, management, pay and benefits
• Policies, guidelines, management support and supervision and the legitimation of activities 
through organisational and structural supports
• The needs of people whose drug use is problematic
‘Rights, Respect and Recovery’ focuses on a Recovery Oriented System of Care approach, which 
fosters the inter-relationships between services to provide a smooth pathway for people who use 
them.  These services include statutory, Third Sector and voluntary services, such as peer supporters. 
This approach is critical to supporting people with complex needs and enables a person-centred 
approach to be at the centre of care planning.
The framework will identify skills and competencies that are required at all levels of the workforce 
and enable ADPs, services and individuals to develop comprehensive learning and development 
plans to achieve and maintain competence.
Workforce Considerations
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Acronyms in this Document
Accident and Emergency
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During the scoping for this report it was established that many ADPs have structures to monitor drug-
related deaths. There were significant variances in scope and practice by the groups. 
It was also found that ADPs often had limited structures for sharing information and learning from 
these reviews.
A review process can provide an insight into local clinical practice, which may drive further 
improvements in that area. 
As near-fatal overdose is a key indicator of later mortality, this section also recommends that DRD 
monitoring groups and services examine near-fatal overdose incidents locally.
Drug-Related Death Monitoring and Learning
Progress (current practice)
Service managers/practitioners across multiple agencies meet and review cases of 
people who have died. Learning is shared with local partners


















DRD review includes assessments of all opioid-related deaths with regards to 
whether naloxone could potentially have been available as an intervention
















Service managers/practitioners across multiple agencies meet and review near-
fatal overdose incidents and apply learning to current practice

















Practitioner learning from discussions with those who have experienced a near-
fatal overdose is communicated at the near-fatal overdose review group
















Data regarding female overdose deaths are regularly reviewed and specific factors 
that may be unique to this group are established to inform service planning

















Staff are supported in the event of a drug-related death and they are involved in 
reviews
















 ADPs include GPs in DRD reviews for people known to their practice

















 ADPs produce an annual drug death prevention report and action plan
















ADPs have regular drug death prevention groups with key partners

















Drug treatment services adopt a no blame culture in the event of a drug-related 
death
















ADPs engage in regional DRD forums to share learning and good practice

















Staff working in drug services and GPs have joint training
















ADPs facilitate educational events for GPs and staff working in drug services






















Being in treatment is a protective factor against drug-related death. The more difficult it is for people 
to access a service, the less likely they are to engage. This applies especially to people who are the 
most vulnerable and marginalised. Services should ensure that they are easily accessible to all and to 
recognise the individual’s right to evidence based healthcare.
Access to Services
Progress (current practice)
Services adopt an ‘all individuals are at high risk’ approach


















The use of multiple substances does not exclude people from treatment
















Fast track referral to service and access to OST is in place for those who have 
experienced a recent, near fatal overdose

















Clear processes are in place for continuation of OST following prison release
















Clear processes are in place for continuation of OST following hospital discharge

















Child protection policies are easily accessed through websites and service 
literature
















All initial contacts with individuals who have care of a child should explain the 
practicalities of how child protection policies operate and what support is available

















Accessible and adequate systems are in place to allow people who use drugs 
(and where appropriate their families and/or representatives) to be involved in 
decisions about their care and to appeal when necessary. These processes should 
be clearly explained
















Accessible, adequate systems are in place for people who use services to make 
complaints and these should be clearly explained and readily visible in service 
literature and waiting rooms

















Staff in drug treatment and support services provide supportive, non-judgemental 
care for people who use drugs, utilising unconditional positive regard
















Staff are aware of the impact of previous trauma on an individual  and understand 
this can impact on their engagement with services

















Drug treatment services have a good understanding of the risk factors in drug-
related deaths among people who use drugs
















All staff working with people who use drugs receive stigma training


















Staff have essential skills training

























An independent expert review of OST in Scotland in 2013 reinforced that there is a strong international 
evidence base for OST as an effective treatment for opioid dependence. A range of evidence based 
opioid replacement therapies should be available. Assessment should be undertaken to ensure 
individuals have choice and are advised of the most appropriate treatment. Injectable options, such 
as diamorphine, should also be considered. Optimal OST is a protective factor against overdose and 
efforts should continue to be made to increase coverage. 
Opioid Substitution Therapy (OST)
Progress (current practice)
Low threshold prescribing (without the expectation that individuals should abstain 
from illicit drugs) is available
















Low threshold services are strongly related to decreased mortality, increased retention rates and are 
associated with reduced opioid use and lower crime rates. Harm reduction approaches to injecting 
drug use have emphasised the importance of lowering the threshold for access to OST for people 
who use drugs. Low threshold programmes aim to reduce negative health outcomes without the 
expectation that individuals should completely abstain from illicit drug use. There is a wide range of 
low threshold prescribing and rapid access practice worldwide. Timeframes for accessing OST should 





Information is available about OST, including benefits and side effects, for 
individuals and their significant others
















Immediate access to OST is available for people experiencing problematic opioid 
use

















People who are receiving treatment are active participants in prescribing decisions
















Electrocardiograms (ECGs) are offered to people who are receiving methadone 
over 100mg daily, and  those who take prescribed medications or substances which 
have potential cardiac side effects















As the risk factors for QTc prolongation increase (such as with daily doses of methadone above 100mg 
or in the presence of multiple risk factors for QTc prolongation) clinicians will need to consider ECGs, 
and these may be carried out in some people before an induction onto methadone, and for others 




Regular reviews of OST (dosing, type and suitability of medication) are held with 
individuals
















Prescribing and pharmacy practices, including dosage of OST, are regularly audited 
and externally reviewed (every 2-3 years)

















Prescribing and pharmacy practices, including dosage of OST, are regularly 
reviewed by  people who have used their services (every 2-3 years)

















Staff providing drug treatment are aware of clinical guidelines and best practice in 
OST prescribing
















Staff in drug treatment services are aware of the stigma of, and barriers to, optimal 
prescribing for the individual



























There would appear to be significant differences in retention rates across the country, although the 
data is limited in terms of providing an accurate picture. There are variations in the recording of 
discharges from services i.e. planned, unplanned and disciplinary. Duty of care considerations to 
highly vulnerable clients should be a key part of all local protocols. 
Retention in Services 
There is a need to explore ways in which services can better engage with those who are most 
vulnerable and marginalised.
Assertive outreach is a model which enhances engagement and is responsive to higher levels of need. 
Assertive outreach models are already in place in some areas and their potential should be further 
explored. Most people experiencing problems related to drugs in Scotland are from disadvantaged 
neighbourhoods and are personally disadvantaged. The association between problem drug use and 
deprivation increases stigmatisation towards people who use drugs
Assertive Outreach
Previous research has found that people who use drugs have high rates of trauma. Being more 
trauma-focussed can involve simply appreciating that many people who use drugs may have been 
traumatised. Assessment, particularly repeated assessment by different practitioners, may become 
highly distressing when people are asked to go over past traumas repeatedly.
Trauma
There is a need for a broader view of who can help meet an individual’s needs. GP services may 
be the primary point of contact with people who are isolated. Pharmacy Needle Exchanges (NEX) 
are another potential single point of contact and contracts should include staff receiving training 
based on the National Injecting Equipment Provision (IEP) guidelines. Pharmacy staff may often have 
contact with people who use drugs who are not in structured treatment and they can be a valuable 




Staff work in accordance with duty of care and the principles of human rights and 
equality
















Assertive outreach principles are embedded in all drug treatment services


















Adult Support and Protection enquiries are considered when individuals have 
multiple morbidities and are deemed to be at high risk of harm
















Increased support mechanisms are available to individuals when they have 
difficulty in engaging in ways expected of them

















There is a clear protocol and description of what constitutes planned, unplanned 
and disciplinary discharges
















Unplanned and disciplinary discharges are reviewed by drug death review groups 
and audited annually

















Services to adopt a no exclusion policy, and any unplanned discharges are 
scrutinised
















Attempts made to prevent unplanned and disciplinary discharges are evidenced 
and recorded

















Referral pathways for GPs to refer into drug treatment services are clear and 
regularly reviewed and updated at least every three years
















Referral numbers from GPs to drug treatment services are audited annually to 
ensure the pathway is effective

















Recovery Orientated Systems of Care are in place which include a trauma-informed 
approach
















Processes are in place for services to rapidly respond if an individual begins to 
disengage from the service

















Solutions are sought to better engage and retain people in treatment
















Systems are in place for people who use the service to be involved in staff 
recruitment, training and appraisal and in the evaluation of services particularly in 
terms of staff engagement

















Staff are supported in the workplace through regular supervision and are 
encouraged to maintain a healthy approach to their work and work/life balance
















Services consider ways in which staff can be supported in managing clients with 
complex and challenging needs


















De-escalation training is available to all staff
















Staff have training in engagement skills to enable them to effectively work with 
people

















Staff are trained in a Recovery Orientated Systems of Care development approach 
to foster effective partnership working
















Staff have specialist training in motivational interviewing





















The sharing of data on near-fatal overdose is key to drug death prevention. The value of identifying 
those who had previously experienced a near-fatal overdose and intervening with this group is 
essential since a near-fatal overdose can be predictive of a subsequent fatal overdose. 
In a few areas protocols have been developed on data sharing between the Scottish Ambulance 
Service and drug treatment services. Anecdotal evidence from ADPs shows that opt-out models for 
referral to services have resulted in higher uptake rates than opt-in models. There is potential for this 
model to be extended to other environments, for example police custody and hospital settings¬
Information Sharing
Progress (current practice)
Information Sharing Protocols (ISPs) are in place between ambulance and drug 
treatment services


















Where ISPs are in place between ambulance and drug treatment services, an opt-
out referral model is utilised
















Where ISPs are in place between ambulance and drug treatment services, an 
assertive outreach model is used

















ISPs are in place between hospital settings and drug treatment services
















ISPs between GPs and drug treatment services are in place

















ISPs between pharmacies involved in dispensing OST and drug treatment services 
are in place
















ISPs between custodial settings and drug treatment services, particularly in relation 
to release dates, are in place

























Injection site and wound-care assessments should be completed regularly with people who inject 
drugs.
This allows the opportunity for front line staff to provide basic wound care and to signpost to more 
specialist health support if appropriate. The provision of specialist wound management and infection 
control services in Scotland is variable. Referral pathways to specialist wound management services 
are not always available or fully utilised. Service planners should consider the points of contact 
individuals have and ensure that wound care provision is available. 
During times of infection outbreak, there are gaps in the dissemination of information to frontline 
staff and those at risk. Areas should ensure a wide coverage of information dissemination including 
all services that people at risk may access. Staff should routinely update their knowledge to enhance 
their skills in this area through training. 
Injecting-related health problems such as blood borne viruses, vein and soft tissue damage and 
bacterial infections are exacerbated for those who inject outdoors. Public places where people 
inject are not sterile environments and, as such, people are at a higher risk of bacterial infections, 
injecting-related complications and also may be more likely to share injecting equipment and related 
paraphernalia.
High Risk Injecting, Wound Care and Bacterial Infections
Progress (current practice)
Local information sharing networks are in place when infection outbreaks occur


















Local protocols are in place in each service detailing actions in the case of bacterial 
infection outbreaks
















Briefings are made available for staff in the event of an outbreak

















All drug service staff/NEX staff make routine enquiries about injection site health
















A Practitioners Guide to Injecting Equipment Provision is available in all services

















Basic and specialised wound care services are in place
















Referral pathways and protocols are in place for wound care

















Assertive outreach is provided by nursing staff for wound care for those who are 
not accessing services
















A local assessment of the prevalence of public injecting has been completed  every 
2-3 years or as required in response to incidents

















Public injecting assessment data is used to consider required responses

















Injecting equipment provision training is available to all staff working in treatment 
and harm reduction services
















Safer injecting training is mandatory for all staff providing services to people who 
use drugs and is updated every 2-3 years


















Basic wound care training is provided to all staff working with people who use 
drugs
















Staff receive Bacterial Infection and Drug Use training

















Drug service staff are trained to promote route transition and alternatives to 
injecting



















Virus Testing  
and Treatment
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BBV is associated with a higher risk of accidental overdose. Hepatitis C appears to be under-reported 
in this high risk cohort and concurrent alcohol use with liver disease heightens mortality risk. 
Hepatitis C remains highly prevalent among people who inject drugs in Scotland. In the context of the 
new highly effective and easy to administer, antiviral therapies, the identification of the thousands 
of individuals who remain undiagnosed or require to be “re-diagnosed” is more critical than ever. 
Not only is treatment so much better in terms of cure rates, but even people with fairly advanced 
disease can benefit greatly from therapy. BBV testing is available to the group; however in some 
areas opportunities to test are missed. 
A recent HIV outbreak among people who inject drugs, highlights the issue of the potential spread of 
HIV. A lack of frontline staff awareness and a delay in testing, monitoring and treatment of individuals 
could result in serious medical issues which will limit their lives. 
There is a need to ensure that all people who have injected drugs, whether they are in drug treatment 
or not, have been tested for BBVs and have received their diagnosis. Support in understanding 
treatment regimes, and when treatment is required, is variable and drug treatment service staff are 
often unsure of HCV and HIV treatment options.
Blood Borne Virus Testing (BBV) and Treatment
Progress (current practice)
BBV testing is offered from all Injecting Equipment Providers


















BBV testing and treatment is offered at all drug treatment services
















BBV testing and treatment is offered at all homelessness services

















Individuals with a positive BBV result are actively encouraged and supported to 
access treatment
















BBV testing is offered at GP practices

















Drug treatment staff are aware of current Hepatitis C Virus treatment options and 
can discuss these with individuals
















Drug treatment staff are aware of HIV treatment options and can discuss these 
with individuals


















BBV training is available to all staff and refreshed every 2-3 years




















Naloxone is an effective intervention in preventing opioid-related overdose deaths once the 
overdose has occurred. Scotland was the first country in the world to introduce a national take home 
naloxone programme in 2011. Since the programme began, naloxone has reportedly been used 
several thousand times to reverse potentially fatal overdoses. Without naloxone availability in the 
community, it is likely that drug-related deaths in Scotland would be considerably higher.
The provision of take home naloxone kits sends a clear message that individual staff, services and 
wider society care about the lives of people who use drugs. To people who are marginalised and may 
be ambivalent at times about their own survival this is a powerful message. With the law change 
in October 2015, people employed or engaged in drug services can supply naloxone to anyone 
likely to witness an overdose. This broadens the scope for naloxone provision as supply is no longer 
restricted to nursing and medical staff. Local analysis should be undertaken to assess where targeted 
distribution can most benefit those at risk. 
With training available to set up peer distribution networks, this is an important opportunity to 
ensure naloxone is available more widely for emergency use.
Naloxone
Progress (current practice)
Assessments have taken place with regards to which services and peer networks 
will supply naloxone


















Coverage of naloxone kits supplied should be assessed based on the local 
prevalence of problem drug use
















Financial provision has been made for the supply of naloxone

















Third sector organisations have naloxone supply frameworks
















Third Sector organisations have volunteer policies in place to allow peer  trainers to 
supply naloxone

















Naloxone peer training networks are available in the community and the prison 
environment. They are inclusive of those who are currently injecting, people with a 
history of drug use and may also include family members
















All services in contact with those at risk of overdose have access to naloxone for 
use in an emergency

















GPs prescribe naloxone to those who may be at risk of, or likely to witness, an 
overdose
















Family members have access to naloxone training and supply

















Monitoring of naloxone supplies is up to date
















All staff working in drug services have been trained in overdose prevention, 
intervention and naloxone

















Anyone receiving OST is provided with naloxone
















Anyone accessing IEP is provided with naloxone

















People leaving residential rehabs and other detox settings are provided with 
naloxone
















People leaving hospital settings are provided with naloxone

















People leaving custodial settings are provided with naloxone

















Overdose prevention, intervention and naloxone training for trainers is available to 
all staff working with people who use drugs, their families and significant others
















Drug treatment staff are trained and equipped to deal with overdose emergencies


















Overdose prevention, intervention and naloxone awareness training and e-learning 
is available to anybody likely to witness an overdose























Throughcare Support is designed to encourage those serving short term sentences to be supported 
in, and on, leaving prison. It works with people to prepare for, and to successfully make, the transition 
from custody into the community. It works collaboratively with individual’s families, colleagues 
and partners to develop an asset-based, individualised plan and officers act as advocates on the 
person’s behalf while encouraging the individual to maintain motivation to change through sustained 
engagement with key services. 
Thoughcare Support
Prison throughcare can support prisoners by carrying out a range of interventions that can reduce the 
risk of death. These include pre-release education about overdose risks and prevention, continuation 
and initiation of substitution treatment and improved referral to aftercare and community treatment 
services.
Monitoring of engagement between prisons and throughcare services should be part of local 
commissioning agreements. 
Prison Release
A large number of people who experience problems related to drugs will have spent time in custody. 
This is an opportunity for engagement and a potential area where various interventions and referral 




Throughcare is in place for all to support re-engagement with services
















There is continuity of care for people on OST on arrival to prison and on release


















Risk assessments are in place prior to release regarding potential drug-related 
death risks
















Families of prisoners are offered overdose awareness and naloxone training

















Pre-release education on overdose risks and prevention is provided
















Individuals at risk of overdose are referred to prison throughcare services

















All night staff prison officers are trained to identify an overdose and respond with 
naloxone
















Support is in place on release from prison that ensures benefits are in place for 
those who are eligible to claim

















Police custody staff are trained on overdose prevention and intervention and 
naloxone is available to them

















Scottish Prison Service staff are trained and equipped to deal with overdose 
emergencies
















Police custody staff are trained and equipped to deal with overdose emergencies


















Throughcare staff training should include being aware of the risks of drug overdose 
and harm reduction practices



















PEOPLE OVER THE 
AGE OF 35 WHO USE 
DRUGS
97
From the ministerial forward to rights, respect and recovery.
We live in a changing landscape in which fewer young people are using alcohol and drugs. However, 
a significant number of the group of people who need our urgent help are older and less healthy
older service users are more likely to present with complex multi-morbidities, often having used 
drugs and alcohol for many years.
While the majority of people who use drugs are male, the recent disproportionate rise in drug-related 
deaths among women has made us consider further the challenges of supporting this group. Services 
are also faced with meeting the often complex needs of a growing group of older people
Making sure that services are accessible to people with disabilities is also a key priority. It is widely 
recognised that many people with problematic substance use have a high incidence of mental and 
physical health problems as a result of, or concurrent with, their substance use. This is particularly 
acute among growing numbers of older people with alcohol and drug problems.
The report Older People with Drug Problems in Scotland: Addressing the needs of an ageing population 
concludes with recommendations to reduce drug deaths in the over 35s. 
These highlight the importance of treating underlying health conditions and facilitating access to 
mainstream health care. Recommendations include embedding assertive outreach into service 
provision and improving accessibility.
Improving mental health, and increasing trauma awareness is an important area of focus of the 
research. Addressing the needs of women, advocacy and reducing isolation for all over 35s is also 
stressed. 
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Progress (current practice)
Nurses and other health practitioners working in drug services identify underlying 
health conditions of people over 35
















Nurses and other health practitioners working with people who use drugs facilitate 
GP registration for their patients


















Nurses and other health practitioners working in drug services provide screening 
and advice in BBV, respiratory, cardiac and digestive health and facilitate access to 
mainstream health care where indicated
















Referral pathways are in place to smoking cessation, pain management clinics, 
respiratory specialists, cardiac and gastroenterology screening and treatment

















People over 35 have access to independent advocacy to ensure understanding and 
exercising of rights with regard to health care and treatment
















Assertive outreach models have been developed to make contact with people over 
35 who use drugs and are not currently engaging with services

















Liaison with GPs and community organisations is in place to identify individuals at 
risk
















Meaningful activity programmes are in place, appropriate to over 35s,  in order to 
reduce isolation

















Pilot projects (including small tests of change) are introduced to generate 
increased evidence and practice models for how to best work with individuals over 
the age of 35
















Staff have awareness of the prevalence of trauma, domestic and gender-based 
violence in women over 35 and referral pathways to appropriate agencies are in 
place to allow early intervention

















Planning in partnership with providers and local authorities is in place for older 
people to access full time care settings such as district nursing, home care and 
nursing homes if and when needed

















Staff enhance their knowledge and experience of working with individuals over 
the age of 35 through specialised training and they are aware of this and it is made 
widely available























Many people suffering a drug-related death have had a specific psychiatric disorder recorded in 
the six months before they died. More generally people with drug problems self-report very high 
levels of anxiety and depression. Mental health awareness and suicide training should be integral 
to all workforce development plans for addiction staff and should be central to addiction staff core 
competencies. There is also a need for better working between mental health and drug treatment 
services. 
Dual Diagnosis and Suicide
Progress (current practice)
Mental health is represented on Alcohol and Drug Partnerships


















Joint working protocols and joint case management takes place between mental 
health and drug treatment services
















DRD review groups consider and assess the numbers of possible intentional 
overdoses and potential suicides are monitored

















Active drug use does not exclude a person from accessing mental health services
















Mental health interventions, such as psychological therapies, are available within 
drug treatment services

















When deterioration in mental health is identified, pathways are in place to increase 
the support available to the individual and staff are aware of these
















Safe plans are developed and reviewed in partnership with people who report 
suicidal ideation or who have an identified risk of suicide

















All staff working with people who use drugs are trained in suicide first aid and 
intervention
















Referral pathways are in place for mental health crisis management and staff are 
aware of these

















Staff working in drug treatment services are trauma aware and  understand, and 
can explain, the link between substance use and the experience of trauma in a way 
that supports people to understand their substance use
















Staff working in mental health services and acute mental health wards have drug 
awareness and overdose prevention and intervention training, and are familiar 
with local services and referral pathways

















Suicide awareness/prevention training is mandatory in drug treatment services
















Mental health awareness training is available in drug treatment services


















Trauma training is available to drug services staff
















Training is provided in Adverse Childhood Experiences

















Staff working with young people have access to relevant training such as Multiple 
Risks and Listening to Children Affected by Parental Substance Use
















Training is provided to staff in order to deliver psychological therapies






















Homelessness can be a contributing factor to drug-related deaths. There may be an under-
representation of homelessness at the time of death as it is not always possible to tell if the person 
was living at a specified address. This is further complicated by “sofa surfing”, the use of bed and 
breakfasts and temporary furnished flats in some areas that are not obviously identified as homeless 
accommodation. 
People who use drugs and who also experience homelessness are vulnerable as a result of multiple 
exclusion issues. People experiencing homelessness are seven times more likely to die of drug-related 
issues than the general population. They also experience health conditions typically found in older 
people in the general population. 
It can be difficult to keep track of where vulnerable individuals are living because of the transient 
nature of experiencing homelessness and, as such, assertive outreach is essential to maintain contact.
Individuals who are actively using substances are entitled to housing and their basic human right to 
shelter should be met.  
Homelessness, Housing and Rough Sleeping
Progress (current practice)
Active drug use does not exclude people from housing and homeless 
accommodation


















Housing First models are adopted that include mainstream housing, shared 
housing and cluster housing
















Housing staff and all agencies working with people experiencing homelessness 
have training in naloxone and it is available for emergency use within services

















Housing and homelessness is represented on ADPs and drug death prevention 
groups and clear links with services are in place
















Measures are in place to prevent and reduce the number of evictions

















Referral pathways are in place between homeless service health staff and drug 
treatment services, and there is a close working relationship between agencies 
working with people experiencing homelessness

















Drug services staff receive training in multiple exclusions and homelessness
















Homeless services staff are trained and equipped to deal with overdose 
emergencies


















Housing staff receive alcohol and drug awareness training



















Women who  
use drugs
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It is important to understand the treatment and care needs of women in what can be a male 
dominated environment. While there are some commonalities, there are also marked differences in 
the motivations and antecedents for alcohol and drug use amongst men and women and differences 
in their care needs, particularly in relation to parental roles. There have been disproportionate rises 
in drug-related deaths in women.
Previous experience of violence or abuse, childhood neglect or parental substance use is relatively 
common among people who use drugs, but is often higher among women. Continuous experiences of 
intimate partner violence towards women are common and women may also have trauma resulting 
from experiences of sex work. Both historical and ongoing trauma can sustain or exacerbate drug 
use, or precipitate relapse. Traumatic experiences, whether predating or occurring during periods 
of drug use, were common among the women participating in the Older People with Drug Problems 
project.
Women Who use Drugs
Progress (current practice)
Women are offered a female worker


















Female only groups and clinics take place
















Staff are aware of the many challenges faced by women who use drugs including 
the stress around being involved with child protection services

















Women are offered sexual health screening, advice and access to specialist sexual 
health services
















Harm reduction services utilise evidence on how to manage drug use during 
pregnancy. Referral pathways are in place between drug treatment services, 
specialist midwife services and family nurse partnerships

















Women are asked if they have ever sold sex and are offered support if appropriate. 
Pathways to specialist services are in place

















Staff in pregnancy services provide evidence based care for pregnant women who 
use drugs
















Staff in Social Work, nurseries and schools should have access to training and 
evidence based information on parental drug use























Although the majority of drug overdose deaths involve opioids – principally heroin - the vast majority 
have multiple drugs present at time of death. 
This is further complicated by the increasing availability of ‘street’ benzodiazepines - often of unknown 
content and quality. There is a lack of information about the metabolic and physical effects of such 
products and the possible effects on short and long-term mental and physical health. Research would 
allow a better understanding of benzodiazepine type drug use which may support the development 
of appropriate strategies to reduce drug-related harms. 
Substitution of street benzodiazepines with prescribed benzodiazepines should be considered.
Fatal and near-fatal cardiac events attributable to stimulant use are not included in official statistics 
including drug death figures.  This results in significant under-reporting of this type of drug-related 
harm. The risks of having a possible heart attack are increased by twenty-three times in the hour 
after cocaine use with risk further increased if alcohol is included. 
Many drug overdose deaths involve prescription medications which may or may not have been 
prescribed to the person.  It is important for treatment services to assess the possible risks to the 
individual arising from interactions between prescribed medication and their possible use of street 
drugs.
Polydrug Use and Prescribed Medicines
Progress (current practice)
Drug treatment services offer advice, information and psycho-social support and 
communicate the risks associated with polydrug use


















Healthcare professionals consult with people receiving drug treatment to discuss 
and monitor the side-effects of prescribed medications, drug use and OST
















Healthcare professionals check blood pressure, pulse and ECGs of people who use 
drugs

















Use of substances, including prescribed medications, does not exclude individuals 
from receiving optimal dose OST
















A&E staff routinely enquire about stimulant use when a person presents with 
symptoms of heart problems, strokes and seizures
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